Resistant to everything.
Mazzullo
J M
JM
Department of Medicine, Tufts University School of Medicine.
Piliero
P J
PJ
D000368:Aged; D018791:CD4 Lymphocyte Count; D002219:Carbamates; D015224:Dideoxynucleosides / Q000008:administration & dosage / Q000627:therapeutic use; D004352:Drug Resistance, Microbial; D004359:Drug Therapy, Combination; D005663:Furans; D015658:HIV Infections / Q000150:complications / Q000188:drug therapy*; D006801:Humans; D061466:Lopinavir; D008297:Male; D010349:Patient Compliance; D011744:Pyrimidinones / Q000008:administration & dosage / Q000627:therapeutic use; D019438:Ritonavir / Q000008:administration & dosage / Q000627:therapeutic use; D018119:Stavudine / Q000008:administration & dosage / Q000627:therapeutic use; D013449:Sulfonamides / Q000008:administration & dosage / Q000627:therapeutic use; D019562:Viral Load; D000099227:Abacavir
D002219:Carbamates; D015224:Dideoxynucleosides; D005663:Furans; D061466:Lopinavir; D011744:Pyrimidinones; D019438:Ritonavir; D018119:Stavudine; D013449:Sulfonamides; D000099227:Abacavir; C095108:amprenavir